Metformin Hydrochloride Rxfarma

Metformin Hydrochloride, the active ingredient in Metformin Hydrochloride Rxfarma, is a biguanide presented as a tablet for oral use. It reduces hepatic glucose production and improves insulin sensitivity in adults with type 2 diabetes mellitus.

GNH USA supplies Metformin Hydrochloride Rxfarma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, sourcing the product from EU‑regulated manufacturers and ensuring quality through rigorous testing and compliance with global standards.

Metformin Hydrochloride is indicated for conditions related to impaired glucose regulation, primarily within the type 2 diabetes therapeutic area.

- Type 2 diabetes mellitus: lowers fasting plasma glucose levels. - Type 2 diabetes mellitus: reduces HbA1c to help achieve glycemic targets. - Type 2 diabetes mellitus: supports diet and exercise regimens as part of comprehensive diabetes management.

Metformin Hydrochloride may cause a range of adverse reactions, most of which are mild and transient.

Common Side Effects: - Gastrointestinal upset: nausea, abdominal discomfort, or diarrhea. - Metallic taste in the mouth. - Decreased vitamin B12 levels with long‑term use. - Mild skin rash or itching. - Headache or dizziness.

Serious or Rare Side Effects: - Lactic acidosis: a rare but life‑threatening metabolic complication. - Severe hypoglycemia when combined with other antidiabetic agents. - Hepatotoxicity: elevated liver enzymes. - Acute pancreatitis. - Severe allergic reactions such as Stevens‑Johnson syndrome.

Metformin Hydrochloride requires careful consideration of patient‑specific factors and monitoring to minimize risks. - Renal function: assess creatinine clearance before initiating therapy and periodically thereafter. - Hepatic impairment: avoid use in patients with significant liver disease. - Cardiovascular status: monitor for signs of heart failure, especially during dose escalation. - Concomitant contrast imaging: discontinue before iodinated contrast procedures to reduce lactic acidosis risk. - Pregnancy and lactation: evaluate risk‑benefit ratio; use only if clearly needed. - Store at ambient temperature: keep below 25 °C, retain in original packaging, and protect from moisture.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - Iodinated contrast agents: may precipitate lactic acidosis; discontinue metformin before and after imaging. - Cimetidine and other potent renal tubular secretion inhibitors: increase metformin plasma concentrations. - Alcohol excess: heightens risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics (especially thiazides): can affect renal clearance of metformin. - Corticosteroids: may raise blood glucose, requiring dose adjustments. - ACE inhibitors or ARBs: monitor renal function and electrolytes when combined.